secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2026-09-15T20:03:10+00:00
Accession:  0001193125-26-391880
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Aligos extends South San Francisco HQ lease to 2034 with rent escalations and termination options
--------------------------------------------------------------------------------

- Lease term extended from March 31, 2027 to March 31, 2034 for One Corporate Drive, 2nd Floor, South San Francisco.
- Base rent per sq ft rises from $4.650 (Apr 2027-Mar 2028) to $5.716 (Apr 2033-Mar 2034).
- Ten-month rent abatement from April 1, 2027 to January 31, 2028, conditional on no material default.
- One-time option to terminate as of March 31, 2031, with $2,476,429.22 termination payment and notice by March 31, 2030.
- Penalty-free termination right if Company signs new lease for at least 60,000 sq ft in Landlord's project.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312526391880/0001193125-26-391880-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312526391880/d120930d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-391880

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer